How did the use of psychotropic drugs change during the Great Recession in Portugal? A follow-up to the National Mental Health Survey.
Age
Economic recession
Gender
Psychotropic drugs
Public health
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
11 05 2020
11 05 2020
Historique:
received:
13
12
2019
accepted:
26
04
2020
entrez:
13
5
2020
pubmed:
13
5
2020
medline:
22
12
2020
Statut:
epublish
Résumé
Research suggests that economic recessions might be associated with a higher use of psychotropic drugs, but literature is scarce and contradictory in identifying the most vulnerable groups. This study aims to assess possible changes in the use of psychotropic drugs due to the economic recession in Portugal, by comparing self-reported consumption in 2008/09 and 2015/16. Data from the World Mental Health Survey Initiative Portugal (2008/09) and the National Mental Health Survey Follow-Up (2015/16) were used (n = 911). McNemar's tests were performed to estimate changes in consumption of any psychotropic drug and of antidepressants, anxiolytics, and hypnotics/sedatives. Multiple Generalised Estimating Equations models with interaction effects were used to estimate the population odds of consuming psychotropic drugs according to year, gender and age. An increase of 6.74% was estimated in the consumption of psychotropic drugs from 2008/09 to 2015/16. Population odds of consuming any psychotropic drugs in 2015/16 were estimated to be 1.5 times higher than in 2008/09 (OR = 1.50;95%CI:1.13-2.01), particularly for hypnotics/sedatives (OR = 1.60;95%CI:1.14-2.25). Women and older individuals presented higher odds of consuming any psychotropic drugs (OR = 2.79;95%CI:2.03-3.84, and OR = 1.80;95%CI:1.28-2.54), after adjusting for year of assessment and education. However, when evaluating the interaction effect of the year with gender and age, men and younger individuals reported higher odds of consuming any psychotropic drugs in 2015/16, when compared to 2008/09 (OR = 1.85;95%CI:1.08-3.17, and OR = 1.95;95%CI:1.32-2.90, respectively). The findings indicate that the period of economic recession was associated with an increased risk of psychotropic drugs use in Portugal. Consumption of psychotropic drugs remained higher among women and older individuals, but the results suggest that the economic crisis had a disproportionate impact on men and younger individuals. This identification of the most vulnerable population groups is useful to design effective and targeted public health interventions aimed at alleviating the effects of economic recessions.
Sections du résumé
BACKGROUND
Research suggests that economic recessions might be associated with a higher use of psychotropic drugs, but literature is scarce and contradictory in identifying the most vulnerable groups. This study aims to assess possible changes in the use of psychotropic drugs due to the economic recession in Portugal, by comparing self-reported consumption in 2008/09 and 2015/16.
METHODS
Data from the World Mental Health Survey Initiative Portugal (2008/09) and the National Mental Health Survey Follow-Up (2015/16) were used (n = 911). McNemar's tests were performed to estimate changes in consumption of any psychotropic drug and of antidepressants, anxiolytics, and hypnotics/sedatives. Multiple Generalised Estimating Equations models with interaction effects were used to estimate the population odds of consuming psychotropic drugs according to year, gender and age.
RESULTS
An increase of 6.74% was estimated in the consumption of psychotropic drugs from 2008/09 to 2015/16. Population odds of consuming any psychotropic drugs in 2015/16 were estimated to be 1.5 times higher than in 2008/09 (OR = 1.50;95%CI:1.13-2.01), particularly for hypnotics/sedatives (OR = 1.60;95%CI:1.14-2.25). Women and older individuals presented higher odds of consuming any psychotropic drugs (OR = 2.79;95%CI:2.03-3.84, and OR = 1.80;95%CI:1.28-2.54), after adjusting for year of assessment and education. However, when evaluating the interaction effect of the year with gender and age, men and younger individuals reported higher odds of consuming any psychotropic drugs in 2015/16, when compared to 2008/09 (OR = 1.85;95%CI:1.08-3.17, and OR = 1.95;95%CI:1.32-2.90, respectively).
CONCLUSIONS
The findings indicate that the period of economic recession was associated with an increased risk of psychotropic drugs use in Portugal. Consumption of psychotropic drugs remained higher among women and older individuals, but the results suggest that the economic crisis had a disproportionate impact on men and younger individuals. This identification of the most vulnerable population groups is useful to design effective and targeted public health interventions aimed at alleviating the effects of economic recessions.
Identifiants
pubmed: 32393219
doi: 10.1186/s12888-020-02620-1
pii: 10.1186/s12888-020-02620-1
pmc: PMC7216710
doi:
Substances chimiques
Psychotropic Drugs
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
215Subventions
Organisme : NIMH NIH HHS
ID : R01 MH070884
Pays : United States
Organisme : NIMH NIH HHS
ID : R13 MH066849
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH069864
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA016558
Pays : United States
Organisme : FIC NIH HHS
ID : R03 TW006481
Pays : United States
Références
Health Policy. 2016 Jul;120(7):833-9
pubmed: 27263063
Epidemiol Psychiatr Sci. 2019 Dec;28(6):638-643
pubmed: 30078385
Lancet. 2013 Apr 13;381(9874):1323-31
pubmed: 23541059
J Epidemiol Community Health. 2006 Jan;60(1):7-12
pubmed: 16361448
Int J Equity Health. 2014 Jul 25;13:55
pubmed: 25062772
Int J Equity Health. 2014 Jul 25;13:53
pubmed: 25062657
Epidemiol Psychiatr Sci. 2018 Nov 13;29:e7
pubmed: 30419997
Psychiatry Res. 2014 Dec 15;220(1-2):615-22
pubmed: 25070175
Gac Sanit. 2014 Jun;28 Suppl 1:104-8
pubmed: 24661346
Health Econ. 2014 Nov;23(11):1301-25
pubmed: 23956154
PLoS One. 2016 Feb 12;11(2):e0148594
pubmed: 26872210
Soc Sci Med. 2016 Mar;153:90-8
pubmed: 26889951
Am J Public Health. 2015 Feb;105(2):304-10
pubmed: 25521885
J Affect Disord. 2008 Sep;110(1-2):84-93
pubmed: 18329721
Psychiatr Q. 2017 Jun;88(2):371-384
pubmed: 27383613
J Affect Disord. 2007 Mar;98(3):189-97
pubmed: 17182105
PLoS One. 2013 Jul 26;8(7):e69792
pubmed: 23922801
Depress Anxiety. 2018 Mar;35(3):195-208
pubmed: 29356216
Eur J Public Health. 2015 Dec;25(6):923-9
pubmed: 26136466
BMC Public Health. 2016 Feb 03;16:115
pubmed: 26847554
Br J Psychiatry. 2017 Feb;210(2):119-124
pubmed: 27908899
BMJ Open. 2019 Jan 22;9(1):e021440
pubmed: 30674485
Eur Arch Psychiatry Clin Neurosci. 2016 Mar;266(2):89-124
pubmed: 26874960
Stat Med. 2004 Mar 30;23(6):859-74; discussion 875-7,879-80
pubmed: 15027075
Eur Psychiatry. 2018 Mar;49:56-61
pubmed: 29366849
Int J Ment Health Syst. 2013 Jul 09;7(1):19
pubmed: 23837605
Eur Psychiatry. 2015 Sep;30(6):778-88
pubmed: 26052073
Neuropsychiatr Dis Treat. 2015 Dec 30;12:29-40
pubmed: 26766910
Sci Rep. 2016 Jul 05;6:29281
pubmed: 27377429
Psychol Med. 2018 Jul;48(10):1644-1654
pubmed: 29095133
Gac Sanit. 2016 Nov - Dec;30(6):464-467
pubmed: 27017197
J Behav Health Serv Res. 2016 Apr;43(2):187-99
pubmed: 24699888
Soc Sci Med. 2016 Jun;158:86-95
pubmed: 27115334
Eur J Clin Pharmacol. 2014 Jul;70(7):849-57
pubmed: 24793010
BMC Health Serv Res. 2012 Nov 30;12:435
pubmed: 23193954
Health Policy. 2006 Dec;79(2-3):231-43
pubmed: 16473436